-
1 Comment
Nihon Chouzai Co.,Ltd is currently in a long term downtrend where the price is trading 1.1% below its 200 day moving average.
From a valuation standpoint, the stock is 99.7% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 0.2.
Nihon Chouzai Co.,Ltd's total revenue rose by 5.2% to $72B since the same quarter in the previous year.
Its net income has increased by 92.2% to $2B since the same quarter in the previous year.
Based on the above factors, Nihon Chouzai Co.,Ltd gets an overall score of 3/5.
| Sector | Healthcare |
|---|---|
| Industry | Pharmaceutical Retailers |
| Exchange | TSE |
| CurrencyCode | JPY |
| ISIN | JP3729200000 |
| Dividend Yield | 0.8% |
|---|---|
| PE Ratio | 108.65 |
| Market Cap | 87B |
| Target Price | 1480 |
| Beta | -0.09 |
NIHON CHOUZAI Co.,Ltd. engages in the management of health insurance dispensing chain pharmacies in Japan. It operates through dispensing pharmacy, pharmaceutical manufacturing and sales, and medical staff dispatching and referral business segments. The company manufactures and sells generic drugs to medical institutions and other pharmacies. In addition, it offers temporary staffing services for pharmacist; and employment services for physicians and registered sales personnel, and other healthcare professionals. Further, the company provides studies and research services for pharmaceutical companies and organizations; information and consulting services for industries associated with pharmaceuticals and healthcare; and other services. NIHON CHOUZAI Co.,Ltd. was incorporated in 1980 and is headquartered in Tokyo, Japan.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for 3341.TSE using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2025
